StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Barclays Downgrades Puma Biotechnology (PBYI) to Underweight
November 2, 2018 4:32 AM
Barclays analyst Gena Wang downgraded Puma Biotechnology (NASDAQ: PBYI) from Equalweight to Underweight with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Downgrades
Hot Downgrades
Next Articles
BofA/Merrill Lynch Downgrades Puma Biotechnology (PBYI) to Underperform
November 2, 2018 9:18 AM
JPMorgan Downgrades Puma Biotechnology (PBYI) to Underweight
November 2, 2018 5:55 AM
Puma Biotech (PBYI) Reports Q3 EPS of $0.17
November 1, 2018 4:17 PM
